Advanced Search
Contact | Corporate | Help

Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (Excluding Squamous Cell)

Sponsors:
  • Stanford University
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: bevacizumab
  • Drug: gemcitabine
  • Procedure: chemotherapy
Enrollment:
50

Additional information about NCT00323869.


SourceSolution © 2008-2012